Belsky, Jennifer A.Carroll, Whitney R.Xu, GuangJacob, Seethal A.2023-11-022023-11-022023Belsky JA, Carroll WR, Xu G, Jacob SA. Side Effects With a Focus on Lymphadenopathy Following COVID-19 Vaccination in Pediatric and AYA Oncology Patients. J Pediatr Hematol Oncol. 2023;45(2):88-90. doi:10.1097/MPH.0000000000002621https://hdl.handle.net/1805/36867The Coronavirus Disease 2019 (COVID-19) pandemic led to the swift development of multiple vaccinations. Vaccine side effects were well-documented in the healthy adult cohort and included fever and lymphadenopathy, however, side effects in the pediatric immunocompromised population have not been reported. This retrospective study investigated vaccine-eligible children and adolescent young adult oncology patients 12 to 35 years old. We found uncommon, mild, and self-limiting side effects among pediatric cancer patients and survivors. This data will help guide pediatric and AYA oncologists in providing anticipatory guidance and serve as a guide to managing lymphadenopathy as a potential confounder of malignancy.en-USPublisher PolicyPediatric oncologySupportive careCOVID-19VaccinationSide Effects With a Focus on Lymphadenopathy Following COVID-19 Vaccination in Pediatric and AYA Oncology PatientsArticle